Popular Pre-Market Trades in U.S. Stocks
Duke Robotics fell 7.64% in pre-market trading, with no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
Lumentum fell 3.44% in pre-market trading. Based on recent news,
<ol>
<li>
On July 6, Whittier Trust Co. increased its holdings in Lumentum by 21,806.5% in the first quarter, holding stocks worth $57.2 million. Institutions such as Advisors Asset Management and NewEdge Advisors also increased their positions, leading to stock price fluctuations.
</li>
<li>
On July 6, the overall timeline for the optical communication and CPO industry chain has been pushed back, with shipments relying on the Rubin Ultra and Kyber platforms' Sidecar delayed to the 2028 window. Analysts maintain a cautious attitude towards Lumentum, affecting market sentiment.
</li>
<li>
On July 4, MarketBeat reported that although Lumentum currently has a moderate buy rating among analysts, top analysts believe there are five stocks that are more worthy of investment, weakening market confidence in Lumentum. The timeline for the optical communication industry chain has shifted, leading to cautious market sentiment.
</li>
</ol>
Top Gainers in Pre-Market Trading in U.S. Stocks
Crinetics Pharmaceuticals rose 98.93% in pre-market trading. Based on recent key news:
<ol>
<li>
On July 7, Fortive Corporation announced the acquisition of Crinetics Pharmaceuticals for $85 per share in cash, totaling approximately $10 billion. This news led to a pre-market surge of 98.93% in Crinetics' stock price.
</li>
<li>
On July 7, Fortive stated that this acquisition would expand its business in the endocrinology field and is expected to have a positive impact on adjusted operating profit by 2029. This news further boosted market confidence.
</li>
<li>
On July 7, analysts changed their ratings on Crinetics, with Oppenheimer analysts downgrading their rating from &#34;Outperform&#34; to &#34;Perform,&#34; while Cantor Fitzgerald analysts downgraded their rating from &#34;Buy&#34; to &#34;Neutral.&#34; Nevertheless, analysts still believe that Crinetics has a strong biotechnology pipeline. The biopharmaceutical industry has performed strongly recently, with significant capital inflow.
</li>
</ol>
Trident Digital Tech rose 67.03% in pre-market trading. Based on recent key news:
<ol>
<li>
On July 6, Trident Digital Tech announced a 240-share consolidation plan and terminated its ADS project, shifting to direct trading of common stock on Nasdaq. This move aims to simplify the trading structure, enhance shareholder value, and drive a significant increase in stock price
</li>
<li>
On July 6, the company announced that it does not undertake any obligation to update any forward-looking statements unless required by law. This statement stabilized investor expectations and further supported the rise in stock prices.
</li>
<li>
On July 6, Trident Digital Tech reached a global partnership with Phoenix MGMT &amp; Consulting, aiming to expand market influence, enhance brand value, boost investor confidence, and drive stock price increases. The overall market performed well, with technology stocks generally rising.
</li>
</ol>
Pupu Culture rose 36.84% in pre-market trading. Based on recent key news:
<ol>
<li>On July 7, Pupu Culture is still seeking its narrative positioning in the global market. Although its role in the market is not yet clear, as a smaller market participant, it is striving to establish a foothold in a complex market environment. Source: Dolphin Research The market environment is complex, and attention should be paid to industry dynamics</li>
</ol>

DUKR

LITE

Duke Robotics pre-market down 7.64%; Lumentum pre-market down 3.44%; Crinetics Pharmaceuticals pre-market up 98.93%; Trident Digital Tech pre-market up 67.03%; Pupu Culture pre-market up 36.84%

Price Alert

Duke Robotics

Pre-market hot trades in US stocks: Duke Robotics pre-market down 7.64%; Lumentum pre-market down 3.44%